Inspire Medical Systems, Inc. Investing Cash Flow
Inspire Medical Systems, Inc. (INSP) reported Investing Cash Flow of -$7.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-03
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $3.55M, a 92.38% decline year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$11.25M.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$11.92M, a 416.88% decline year-over-year.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$11.64M.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $21.45M.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$113.12M.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$294.82M.
- Inspire Medical Systems, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$19.60M, a 167.25% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | -$7.70M 10-Q · filed 2026-08-03 | -$19.62M derived: sum of 3 quarters · filed 2026-08-03 | -$31.26M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$11.25M 10-Q · filed 2026-05-04 | -$23.17M derived: sum of 2 quarters · filed 2026-05-04 | -$34.81M derived: sum of 3 quarters · filed 2026-05-04 | $11.75M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$11.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$23.56M derived: sum of 2 quarters · filed 2026-02-13 | $23.00M derived: sum of 3 quarters · filed 2026-08-03 | $21.45M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$11.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $34.92M derived: sum of 2 quarters · filed 2026-08-03 | $33.36M 10-Q · filed 2025-11-03 | $37.13M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $46.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $45.01M 10-Q · filed 2026-08-03 | $48.77M derived: sum of 3 quarters · filed 2026-08-03 | -$54.20M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$1.55M 10-Q · filed 2026-05-04 | $2.21M derived: sum of 2 quarters · filed 2026-05-04 | -$100.76M derived: sum of 3 quarters · filed 2026-05-04 | -$95.14M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$99.21M derived: sum of 2 quarters · filed 2026-02-13 | -$93.59M derived: sum of 3 quarters · filed 2026-02-13 | -$113.12M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$102.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$97.35M derived: sum of 2 quarters · filed 2025-11-03 | -$116.88M 10-Q · filed 2025-11-03 | -$268.61M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $5.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$13.91M 10-Q · filed 2025-08-04 | -$165.64M derived: sum of 3 quarters · filed 2026-02-13 | -$309.88M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$19.54M 10-Q · filed 2025-05-05 | -$171.26M derived: sum of 2 quarters · filed 2026-02-13 | -$315.50M derived: sum of 3 quarters · filed 2026-02-13 | -$310.60M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$151.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$295.96M derived: sum of 2 quarters · filed 2026-02-13 | -$291.07M derived: sum of 3 quarters · filed 2026-02-13 | -$294.82M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$144.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$139.35M derived: sum of 2 quarters · filed 2024-11-04 | -$143.10M 10-Q · filed 2024-11-04 | -$146.05M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $4.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.14M 10-Q · filed 2024-08-06 | -$1.81M derived: sum of 3 quarters · filed 2025-02-10 | -$5.57M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$3.75M 10-Q · filed 2024-05-07 | -$6.70M derived: sum of 2 quarters · filed 2025-02-10 | -$10.46M derived: sum of 3 quarters · filed 2025-02-10 | -$21.88M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | -$2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | -$6.71M derived: sum of 2 quarters · filed 2025-02-10 | -$18.13M derived: sum of 3 quarters · filed 2025-02-10 | -$19.60M 10-K · filed 2025-02-10 |
| 2022-09-30 | -$3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$15.18M derived: sum of 2 quarters · filed 2023-11-07 | -$16.65M 10-Q · filed 2023-11-07 | -$17.18M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | -$11.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$12.88M 10-Q · filed 2023-08-01 | -$13.42M derived: sum of 3 quarters · filed 2024-02-09 | $16.73M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | -$1.47M 10-Q · filed 2023-05-02 | -$2.00M derived: sum of 2 quarters · filed 2024-02-09 | $28.15M derived: sum of 3 quarters · filed 2024-02-09 | $29.00M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | -$533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $29.62M derived: sum of 2 quarters · filed 2024-02-09 | $30.46M derived: sum of 3 quarters · filed 2024-02-09 | $29.14M 10-K · filed 2024-02-09 |
| 2021-09-30 | $30.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $30.99M derived: sum of 2 quarters · filed 2022-11-01 | $29.67M 10-Q · filed 2022-11-01 | $41.07M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $844.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$477.00K 10-Q · filed 2022-08-02 | $10.92M derived: sum of 3 quarters · filed 2023-02-10 | -$15.01M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | -$1.32M 10-Q · filed 2022-05-03 | $10.07M derived: sum of 2 quarters · filed 2023-02-10 | -$15.85M derived: sum of 3 quarters · filed 2023-02-10 | $18.07M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | -$14.53M derived: sum of 2 quarters · filed 2023-02-10 | $19.39M derived: sum of 3 quarters · filed 2023-02-10 | $86.63M 10-K · filed 2023-02-10 |
| 2020-09-30 | -$25.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $7.99M derived: sum of 2 quarters · filed 2021-11-02 | $75.23M 10-Q · filed 2021-11-02 | $55.24M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $33.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $101.16M 10-Q · filed 2021-08-03 | $81.17M derived: sum of 3 quarters · filed 2022-02-15 | $80.67M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $67.24M 10-Q · filed 2021-05-04 | $47.25M derived: sum of 2 quarters · filed 2022-02-15 | $46.75M derived: sum of 3 quarters · filed 2022-02-15 | $7.73M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$19.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$20.49M derived: sum of 2 quarters · filed 2022-02-15 | -$59.52M derived: sum of 3 quarters · filed 2022-02-15 | -$43.56M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$501.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$39.52M derived: sum of 2 quarters · filed 2020-11-02 | -$23.57M 10-Q · filed 2020-11-02 | -$19.95M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$39.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$23.07M 10-Q · filed 2020-08-04 | -$19.44M derived: sum of 3 quarters · filed 2021-02-24 | -$111.48M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $15.96M 10-Q · filed 2020-05-05 | $19.58M derived: sum of 2 quarters · filed 2021-02-24 | -$72.46M derived: sum of 3 quarters · filed 2021-02-24 | -$67.86M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$88.41M derived: sum of 2 quarters · filed 2021-02-24 | -$83.81M derived: sum of 3 quarters · filed 2021-02-24 | -$83.39M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$92.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$87.44M derived: sum of 2 quarters · filed 2019-11-05 | -$87.01M 10-Q · filed 2019-11-05 | -$89.46M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.02M 10-Q · filed 2019-08-06 | $2.58M derived: sum of 3 quarters · filed 2020-02-25 | -$2.35M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $425.00K 10-Q · filed 2019-05-07 | -$2.02M derived: sum of 2 quarters · filed 2020-02-25 | -$6.95M derived: sum of 3 quarters · filed 2020-02-25 | -$6.97M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$7.37M derived: sum of 2 quarters · filed 2020-02-25 | -$7.39M derived: sum of 3 quarters · filed 2020-02-25 | -$7.60M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$4.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$4.95M derived: sum of 2 quarters · filed 2018-11-06 | -$5.15M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$226.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$206.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | -$306.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |